These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36440189)

  • 1. Metformin use and mortality and length of stay among hospitalized patients with type 2 diabetes and COVID-19: A multiracial, multiethnic, urban observational study.
    Miao E; Zhang K; Liu J; Lin J; Yoo D; George CJ
    Front Endocrinol (Lausanne); 2022; 13():1002834. PubMed ID: 36440189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin is associated with favorable outcomes in patients with COVID-19 and type 2 diabetes mellitus.
    Ma Z; Patel N; Vemparala P; Krishnamurthy M
    Sci Rep; 2022 Apr; 12(1):5553. PubMed ID: 35365744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study.
    Cheng X; Xin S; Chen Y; Li L; Chen W; Li W; Zhou B; Li C; Gong Y; Li F; Duan P; Zhou X
    Life Sci; 2021 Jun; 275():119371. PubMed ID: 33745895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis.
    Luo P; Qiu L; Liu Y; Liu XL; Zheng JL; Xue HY; Liu WH; Liu D; Li J
    Am J Trop Med Hyg; 2020 Jul; 103(1):69-72. PubMed ID: 32446312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Use in Relation to Clinical Outcomes and Hyperinflammatory Syndrome Among COVID-19 Patients With Type 2 Diabetes: A Propensity Score Analysis of a Territory-Wide Cohort.
    Wong CKH; Lui DTW; Lui AYC; Low MCH; Kwok ACY; Lau KTK; Au ICH; Xiong X; Chung MSH; Lau EHY; Cowling BJ
    Front Endocrinol (Lausanne); 2022; 13():810914. PubMed ID: 35321338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19.
    Lalau JD; Al-Salameh A; Hadjadj S; Goronflot T; Wiernsperger N; Pichelin M; Allix I; Amadou C; Bourron O; Duriez T; Gautier JF; Dutour A; Gonfroy C; Gouet D; Joubert M; Julier I; Larger E; Marchand L; Marre M; Meyer L; Olivier F; Prevost G; Quiniou P; Raffaitin-Cardin C; Roussel R; Saulnier PJ; Seret-Begue D; Thivolet C; Vatier C; Desailloud R; Wargny M; Gourdy P; Cariou B;
    Diabetes Metab; 2021 Sep; 47(5):101216. PubMed ID: 33309936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis.
    Ma Z; Krishnamurthy M
    PLoS One; 2023; 18(2):e0282210. PubMed ID: 36821577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA.
    Ghany R; Palacio A; Dawkins E; Chen G; McCarter D; Forbes E; Chung B; Tamariz L
    Diabetes Metab Syndr; 2021; 15(2):513-518. PubMed ID: 33662839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?
    Do JY; Kim SW; Park JW; Cho KH; Kang SH
    Diabetes Metab; 2021 Jul; 47(4):101208. PubMed ID: 33160030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy.
    Ojeda-Fernández L; Foresta A; Macaluso G; Colacioppo P; Tettamanti M; Zambon A; Genovese S; Fortino I; Leoni O; Roncaglioni MC; Baviera M
    Diabetes Obes Metab; 2022 May; 24(5):891-898. PubMed ID: 35014746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review.
    Plowman TJ; Christensen H; Aiges M; Fernandez E; Shah MH; Ramana KV
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preadmission usage of metformin and mortality in COVID-19 patients including the post-discharge period.
    Saygili ES; Karakiliç E; Mert E; Şener A; Mirci A
    Ir J Med Sci; 2022 Apr; 191(2):569-575. PubMed ID: 34713419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.
    Zangiabadian M; Nejadghaderi SA; Zahmatkesh MM; Hajikhani B; Mirsaeidi M; Nasiri MJ
    Front Endocrinol (Lausanne); 2021; 12():645194. PubMed ID: 33815295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Metformin, Insulin on Hematological Parameters of COVID-19 Patients with Type 2 Diabetes.
    Petakh P; Griga V; Mohammed IB; Loshak K; Poliak I; Kamyshnyiy A
    Med Arch; 2022 Oct; 76(5):329-332. PubMed ID: 36545453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inpatient use of metformin and acarbose is associated with reduced mortality of COVID-19 patients with type 2 diabetes mellitus.
    Li J; Wei Q; McCowen KC; Xiong W; Liu J; Jiang W; Thomas RL; Hepokoski M; He M; Shyy JYJ; Malhotra A; Xiong N; Li WX
    Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00301. PubMed ID: 34585841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study.
    Jiang N; Chen Z; Liu L; Yin X; Yang H; Tan X; Wang J; Li H; Tian M; Lu Z; Xiong N; Gong Y
    Diabetes Res Clin Pract; 2021 Mar; 173():108619. PubMed ID: 33310173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus.
    Yen FS; Wang SI; Lin SY; Wei JC
    Diabetes Res Clin Pract; 2023 Jun; 200():110692. PubMed ID: 37156428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes.
    Crouse AB; Grimes T; Li P; Might M; Ovalle F; Shalev A
    Front Endocrinol (Lausanne); 2020; 11():600439. PubMed ID: 33519709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin use associated with lower rate of hospitalization for influenza in individuals with diabetes.
    Greene E; Green CL; Hurst J; MacIver NJ
    Diabetes Obes Metab; 2024 Aug; 26(8):3281-3289. PubMed ID: 38742467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.